Nature Nanotechnology - July issue

How to harness nanomaterials’ potential while ensuring safety? See the article on key advances in new tools/approaches. Authors include Douglas Connect's Managing director Barry Hardy and Scientific Project Manager Lucian Farcal.

Engineered nanomaterials (ENMs) are already being deployed across many sectors and their potential, both economic and scientific, is vast.

But how can we best assess and ensure their safety? An article in the July issue of Nature Nanotechnology presents much-needed perspective on key advances in tools and approaches.

Managing Director of Douglas Connect, Barry Hardy, and Scientific Project Manager Lucian Farcal are among the international authors who pooled their knowledge on the subject.

ABSTRACT

Engineered nanomaterials (ENMs) have tremendous potential to produce beneficial technological impact in numerous sectors in society. Safety assessment is, of course, of paramount importance. However, the myriad variations of ENM properties makes the identification of specific features driving toxicity challenging. At the same time, reducing animal tests by introducing alternative and/or predictive in vitro and in silico methods has become a priority. It is important to embrace these new advances in the safety assessment of ENMs.

Indeed, remarkable progress has been made in recent years with respect to mechanism-based hazard assessment of ENMs, including systems biology approaches as well as high-throughput screening platforms, and new tools are also emerging in risk assessment and risk management for humans and the environment across the whole life-cycle of nano-enabled products. Here, we highlight some of the key advances in the hazard and risk assessment of ENMs.

About Edelweiss Connect

Edelweiss Connect has developed computer software that helps combine data from many different sources and formats into a useable form for evaluation and re-use. In addition, we have developed other software programs that can use the collected data and data from in vitro tests to predict the safety of chemical compounds in the human body.

Tags

Latest Tweets

Edelweiss Connect (5 weeks ago)
RT @openrisknet: Meet us @ISMBinfo @iscb #ISMBECCB 2019 conference in #Basel, #Switzerland and learn about our tools and solutions on #comp…
Edelweiss Connect (2 months ago)
RT @iseult5: @nanocommons month18 meeting well underway! Updates from Cristiana on project status and @EdelweissConn Thomas Exner on our #n…
Edelweiss Connect (2 months ago)
RT @openrisknet: We are pleased to announce the final @OpenRiskNet workshop that will be organised in #Amsterdam, The Netherlands on 23-24…
Edelweiss Connect (2 months ago)
RT @MauriceAtEcvam: We're hiring! If you are specialist in organ-on-chip technologies and systems then please apply to come join our team @…
Edelweiss Connect (2 months ago)
RT @nanotechia: Come say hi to @EdelweissConn at #Nanopavilion2019 Stand B316 at #ChemspecEurope ! #nano #nanomaterials #nanotechnology ht…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 633 29 78
  • Email: info@edelweissconnect.com

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA
  • Phone: +1 252 654 9003
  • Email: info@edelweissconnect.com